Clinical Trial Access
Access to clinical trials remains a significant challenge, with less than 5% of lung cancer patients having potential access. Many doctors drop out of research after their first study, highlighting a critical gap in both awareness and motivation. The discussion reveals that trials operate as a niche care setting, suggesting a need for improved support and resources for both patients and physicians.In this clip
From this podcast
Raising Health
Transforming Clinical Trials with Alexander Saint-Amand
Related Questions